Filamin-A as a marker and target for DNA damage based cancer therapy.
about
Identification of the DNA repair defects in a case of Dubowitz syndromeIntegrated proteomics identified up-regulated focal adhesion-mediated proteins in human squamous cell carcinoma in an orthotopic murine model.SQSTM1/p62 mediates crosstalk between autophagy and the UPS in DNA repair.Circulating anti-filamin C autoantibody as a potential serum biomarker for low-grade gliomas.Dysregulation of RNA polymerase I transcription during disease.Proteomic analysis of zoledronic-acid resistant prostate cancer cells unveils novel pathways characterizing an invasive phenotype.Prognostic values of filamin-A status for topoisomerase II poison chemotherapyInhibition of filamin-A reduces cancer metastatic potentialComplex roles of filamin-A mediated cytoskeleton network in cancer progression.SERPINB1 expression is predictive for sensitivity and outcome of cisplatin-based chemotherapy in melanoma.Proteomic analysis of the vitamin C effect on the doxorubicin cytotoxicity in the MCF-7 breast cancer cell line.Secretome proteins as candidate biomarkers for aggressive thyroid carcinomas.Filamin A expression predicts early recurrence of hepatocellular carcinoma after hepatectomy.Filamin A inhibits tumor progression through regulating BRCA1 expression in human breast cancer
P2860
Q28485308-804CD2CB-5821-4F61-8732-20ADEEB0130BQ28539107-AFE05363-F0E3-41D2-9EE6-DFCFF287DAEBQ33564150-70C430EB-8893-44E8-8074-4BC2E4FD7DC8Q33890619-7064FACF-6936-42D6-8154-50EC97104456Q34645436-61D56190-D4BA-40A3-BFFE-8C311DBDFC23Q35497211-6846A31E-9B4E-4389-ACE4-2FC358D0BDACQ35828535-8902A134-D708-45FE-BC47-FEC1DF355547Q36503992-8AAF11F9-D446-403E-A18E-29CD665EA8F2Q36614195-50E4E1A1-1818-4D1B-B9FF-F7BD550B4B55Q36962895-14FF4273-4F81-45DD-9F3C-66DFD476DEC7Q38746649-B305B5C1-5AE8-453E-8071-EE4EAC9B9A8CQ39210485-618BD8D6-EA31-45F0-814A-685926C87750Q40115217-B6CFDA17-108A-4925-9442-F94EAD6DC0C7Q58572892-BA643946-B69F-4FBD-92A3-153764AAEDD2
P2860
Filamin-A as a marker and target for DNA damage based cancer therapy.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Filamin-A as a marker and target for DNA damage based cancer therapy.
@en
Filamin-A as a marker and target for DNA damage based cancer therapy.
@nl
type
label
Filamin-A as a marker and target for DNA damage based cancer therapy.
@en
Filamin-A as a marker and target for DNA damage based cancer therapy.
@nl
prefLabel
Filamin-A as a marker and target for DNA damage based cancer therapy.
@en
Filamin-A as a marker and target for DNA damage based cancer therapy.
@nl
P2093
P2860
P1433
P1476
Filamin-A as a marker and target for DNA damage based cancer therapy
@en
P2093
Jingmei Liu
Jingyin Yue
Zhiyuan Shen
P2860
P304
P356
10.1016/J.DNAREP.2011.10.019
P577
2011-11-02T00:00:00Z